ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates

ADC Therapeutics SA (ADCT) came out with a quarterly loss of $1.03 per share versus the Zacks Consensus Estimate of a loss of$ 0.47. This compares to loss of $0.30 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -119.15%. A quarter ago, it was expected that this company would post a loss of$ 0.61 per share when it actually produced a loss of $0.58, delivering a surprise of 4.92%.Over the last four quarters, the company has sur ...